Bimal Malhotra - Concepedia

Author

Bimal Malhotra

Also Known As

B K Malhotra, B Malhotra, B. Malhotra, B.K. Malhotra, Bimal K Malhotra, Bimal K. Malhotra, Bimal K. Malhotra, PhD, Bimal Malhotra, Bimal Malhotra, PhD, Hidetomi Yamagami

Publications

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Pfizer (United Kingdom)Duke Medical Center Bristol-Myers Squibb (United States)UCB Pharma (Germany)

About

Bimal Malhotra is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	322
2	Health Sciences	2	2	40
3	Natural Sciences	1	1	19
4	Allergy	1	1	24
5	Allergy Medicine	1	1	24

Bimal Malhotra

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, New England Journal of Medicine	2021	419
A comprehensive non‐clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder Ernesto Callegari, Bimal Malhotra, Peter J. Bungay, British Journal of Clinical Pharmacology	2011	178
Thorough QT Study with Recommended and Supratherapeutic Doses of Tolterodine Bimal Malhotra, Paul Glue, Kevin Sweeney, Clinical Pharmacology & Therapeutics Drug SafetyTherapeutic Drug MonitoringQtc EffectsMedicineClinical Pharmacology	2007	80
Pharmacokinetic profile of fesoterodine Bimal Malhotra, Zhiwei Guan, Nolan Wood, International Journal of Clinical Pharmacology and Therapeutics	2008	70
Evaluation of Cognitive Function in Healthy Older Subjects Treated with Fesoterodine Gary G. Kay, Paul Maruff, David Scholfield, Postgraduate Medicine	2012	64
Percutaneous Absorption and Pharmacokinetics of Eflornithine HCl 13.9% Cream in Women with Unwanted Facial Hair Bimal Malhotra, Robert J. Noveck, Dan Behr, The Journal of Clinical Pharmacology Unwanted Facial HairMedicineTopical DrugClinical DermatologyToxicology	2001	44
Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites Ellen Q. Wang, Vu Le, Melissa O’Gorman, The Journal of Clinical Pharmacology	2021	38
Effects of the moderate CYP3A4 inhibitor, fluconazole, on the pharmacokinetics of fesoterodine in healthy subjects Bimal Malhotra, Maurice Dickins, Christine Alvey, British Journal of Clinical Pharmacology	2011	34
Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: A double-blind, placebo-controlled, randomized, crossover trial* John D. Parker, Bradley A. Bart, David J. Webb, Critical Care Medicine	2007	34
Influence of age, gender, and race on pharmacokinetics, pharmacodynamics, and safety of fesoterodine Bimal Malhotra, Nolan Wood, Richard Sachse International Journal of Clinical Pharmacology and Therapeutics	2009	34

Page 1